Title:
sFcγRIIbまたはsFcγRIIIを含有する医薬品組成物
Document Type and Number:
Japanese Patent JP5414959
Kind Code:
B2
Abstract:
The present invention concerns pharmaceutical compositions containing one of the receptors FcgammaR IIa, FcgammaR IIb or FcgammaR III in a recombinantly produced, soluble form and their use to treat diseases or conditions which are caused by overshooting immune reactions and a pathologically increased formation of antibodies, in particular of autoantibodies. Multiple sclerosis, systemic lupus erythematosus and rheumatoid arthritis are particularly important fields of application.
More Like This:
| JP2013079256 | GLP-1 PEGYLATED COMPOUNDS |
| WO/1997/037010 | ACTIVE SURVIVAL DOMAINS OF IGF-IR AND METHODS OF USE |
| WO/1987/004714 | POLYPEPTIDE WITH INTERLEUKIN-2 ACTIVITY |
Inventors:
Robert Hoover
Peter Zonderman
Uwe Jakob
Peter Zonderman
Uwe Jakob
Application Number:
JP2003545329A
Publication Date:
February 12, 2014
Filing Date:
November 21, 2002
Export Citation:
Assignee:
Max-Planck-Gesellschaft zur Foerderung der Wissenschaften e.V.
International Classes:
A61K38/00; C12N15/09; A61K38/17; A61P37/00; A61P37/02
Foreign References:
| WO2000032767A1 |
Other References:
J.Exp.Med.,Vol.178,No.5,1993,1617-1628
Attorney, Agent or Firm:
Takuya Kuno
Toshio Yano
Einzel Felix-Reinhard
Shuichi Sumiyoshi
Toshio Yano
Einzel Felix-Reinhard
Shuichi Sumiyoshi